Unilateral reciprocal drug approval—granting automatic domestic marketing clearance to pharmaceuticals and medical devices approved by rigorous peer regulators (EMA, MHRA, PMDA)—would eliminate redundant clinical trials and terminate lethal administrative delays. marginalrevolution.com